Orevandrodeg (USAN)
2-[(2S,6R)-4-[2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]cyclohexyl]oxyethyl]-2,6-dimethylpiperazin-1-yl]-N-[3-[[(3S)-2,6-dioxopiperidin-3-yl]amino]phenyl]acetamide
Molecular Identity
Orevandrodeg (USAN)
2-[(2S,6R)-4-[2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]cyclohexyl]oxyethyl]-2,6-dimethylpiperazin-1-yl]-N-[3-[[(3S)-2,6-dioxopiperidin-3-yl]amino]phenyl]acetamide
PubChem CID: 166909510
2D Structure
Properties
C39H48F3N9O5S
Molecular Formula
811.90
Molecular Weight
g/mol
811.3451
Exact Mass
Da
3.9
XLogP
Drug-like (Lipinski: < 5)
195
TPSA
May have limited oral absorption
3
H-Bond Donors
14
H-Bond Acceptors
1560
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(17)
Orevandrodeg (USAN)OREVANDRODEG [USAN]2756845-16-4Orevandrodegorevandrodeg [INN]T7EWZ7DNR7SCHEMBL24140645SCHEMBL30403668BMS986460BMS 986460 [WHO-DD]BMS-986460BMT-632526CC2043137CC-2043137D13211
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Orevandrodeg (USAN)
Loading drug network...